Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim combined with cyclosporine for non-severe aplastic anemia
ChiCTR2500096280Phase 2Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Aug 2024
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of romiplostim and cyclosporine in aplastic anemia, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Complete blood count and Overall response rate. Started Aug 2024; status: recruiting.
02
Drugs
romiplostimcyclosporine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR2500096280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096280.